Literature DB >> 12221671

High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.

Nazanine Bayani1, Michel Rugina, Laurence Haddad-Vergnes, Françoise Lelong.   

Abstract

We report a 79-year-old man with two simultaneous malignant tumors (buccal epidermoid carcinoma and prostatic adenocarcinoma) who developed a severe bleeding complication at the site of the buccal tumor as well as a massive cerebral hematoma after a skull trauma. Laboratory findings showed the presence of a high-titer specific factor V inhibitor. The patient failed to respond to intravenous immunoglobulins, but both clinical and laboratory improvement was obtained after treatment with corticosteroids and cyclophosphamide. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221671     DOI: 10.1002/ajh.10172

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

Review 1.  Acquired factor V inhibitors: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening.

Authors:  Keyur Thakar; Kaushal Parikh; Yamei Chen; Delong Liu
Journal:  Stem Cell Investig       Date:  2014-02-08

3.  Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature.

Authors:  Qing-ya Cui; Hong-shi Shen; Tian-qin Wu; Hai-fei Chen; Zi-qiang Yu; Zhao-yue Wang
Journal:  Drug Des Devel Ther       Date:  2015-04-24       Impact factor: 4.162

4.  Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma.

Authors:  Osamu Imataki; Takeshi Arai; Makiko Uemura
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

5.  High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.

Authors:  Keiichi Nakata; Shuji Ueda; Hitomi Matsunaga; Fuka Mima; Hiroki Ueda; Aya Yoshioka; Sayoko Kaneko; Kazushi Maruo; Shayne Morris; Sayoko Yonemoto; Daisuke Hayashi; Naohiko Fujii; Hiroyuki Narahara; Yoshiaki Inui; Sumio Kawata
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

6.  Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog.

Authors:  Joseph Masciana; Nathan Peterson; John Chretin
Journal:  J Vet Intern Med       Date:  2020-07-20       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.